Statements of Support and Video Tributes:
Scores of patients – including doctors, major business and health care executives, lawyers, esteemed scientists, politicians and military leaders – credited Dr. Nicholas Gonzalez with life changing results. Dr. Gonzalez received recognition and funding of his work by the NIH, Nestle, and Proctor & Gamble. Despite the bad (and later corrected) legal advice from a prestigious (but soon after disbarred lawyer) that exposed Dr. Gonzalez to 2 malpractice claims, Dr. Gonzalez persevered.
Statements of Support from Prominent Researchers
Procter & Gamble and Nestle, both major mainstream corporations, have quite generously supported both laboratory and clinical studies of The Gonzalez Protocol®. Below are statements of support from both the former Vice President of Research in Health Care at P&G and the former Vice President of Nestle, who previously served as Medical Director of the Pasteur Institute, one of the world’s preeminent research centers.
The late Robert W. Maver, a trained statistician and executive at Mutual Benefit Life, became interested in Dr. Gonzalez’s work after he heard of unusually good outcomes in patients covered by the company. After a four-month investigation, he wrote this article for the company’s research division newsletter.
Testimonial of J. P. Jones, Ph.D.
I was Vice President, Research and Development, for one of the largest healthcare companies in the world. We subsidized some of Dr. Gonzalez’s research because, as we formally acknowledged, his work had “extraordinary importance and potential for commercial exploitation,” and his clinical pancreatic cancer trials “had extremely positive results”.
We learned of Dr. Gonzalez by serendipity. An engineer at the company was diagnosed with advanced pancreatic cancer. Another employee said he had heard about Dr. Gonzalez on television. We located Dr. Gonzalez, and the engineer thrived on his program, living three years. The engineer told me that his surgeon was astonished by his survival. He died when, for reasons unrelated to Dr. Gonzalez, he left the program.
We investigated Dr. Gonzalez for a period of six to nine months before we subsidized him. We quickly decided to recruit him, investing substantial sums in the recruitment process because we were convinced he had a valuable program.
During the recruitment period, I invited Dr. Gonzalez to present a seminar for our community. I then reviewed the project at the highest management levels of the company. Their reaction was, literally, that it was one of the most exciting projects ever seen in the history of the company. Everyone supported the idea of moving forward, including the president, the CEO, the businesspeople in healthcare, and research and development.
We are a mainstream company. We believed that Dr. Gonzalez was the next Barry Marshall, and that the scientific implications of his work were phenomenal.
I did considerable due diligence before we subsidized Dr. Gonzalez’s work. I interviewed some of Dr. Gonzalez’s patients, saw their files, spent many hours with Dr. Gonzalez, and studied his many lectures. I also consulted with my wife, a researcher in oncology and hematology. She became so impressed that, despite no illness, she went on Dr. Gonzalez’s program, as did I, and many others at the company. We did so despite lack of insurance reimbursement for the annual expense for dietary supplements. It was the one and only thing I had ever done that made an obvious difference in my health. The difference was “day and night”. Both my wife and I continue on the program to this day, more than a decade later, with extremely positive results. Our experience was shared by more than a dozen others at the company.
Dr. John Paul Jones
Testimonial of Pierre Guesry, M.D.
I am the former Medical Director of the Pasteur Institute in Paris, France, a medical research institution.
I met Dr. Gonzalez in 1992, when I was vice president of research for the Nestle Company, the world’s largest food company.
I told Dr. Gonzalez that I did not believe in his therapy. I then reviewed Dr. Gonzalez’s patient records for persons with very severe cancer whose diagnosis was confirmed by reputable hospitals and universities. I, myself, looked at the x rays, biopsies, and test results to be sure the cases were legitimate. This involved dozens of cases, far too many to suggest coincidental results. To my surprise, I determined that they were all legitimate.
Never did I see an instance where Dr. Gonzalez had treated a patient for a condition for which there was a scientifically established, conventional method of treatment. Additionally, never did I see an instance where his treatment harmed people.
Pierre Guesry, M.D.
Below are links to some memorial tributes to and recognition of Dr. Gonzalez from his friends, colleagues, and patients.
The July/August 2016 issue of the peer review Medline-indexed medical journal Alternative Therapies in Health and Medicine (ATHM) has published five articles by colleagues of Dr. Gonzalez and a case history documenting the treatment of a patient with insulin-dependent diabetes by Dr. Gonzalez himself. Please visit this page at ATHM for the issue’s table of contents.
Tributes from colleagues, patients and Dr. Gonzalez’s widow: Alternative Therapies in Health and Medicine Tribute Book: The Gonzalez Protocol®.
Memorial Service: On June 21, 2016 a moving memorial service for Dr. Gonzalez, attended by family, friends, patients, and colleagues, was held at the historic Saint James’ Church in New York City. Click here to read an article about the service.
Suzanne Somers: Dr. Nicholas Gonzalez Tribute: A moving video tribute recorded in 2015 by noted author and award-winning actress Suzanne Somers.
Peter B. Chowka: Nicholas Gonzalez, M.D.: A Tribute To a Remarkable Man 2016: Dr. Gonzalez’s journalist friend of a quarter century weighs in
Louise Kuo Habakus: A Tribute to Nick Gonzalez, M.D.
Kelly Brogan, M.D.: Celebrating Dr. Nicholas Gonzalez, A Legend In His Time: Leading holistic psychiatrist Dr. Brogan celebrates Dr. Gonzalez
Read about Patient Testimonials and Praise
